CIK 0001420720
- Non-accelerated filer
- Smaller reporting company
iBio, Inc.
Sign in to watch- Ticker
- IBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262797813
- Phone
- +1 302-355-0650
- Business address
- 600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
- Former names
- iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-24 | Brenner Martin See Remarks | Sale | −4,382 | $1.20 | $5K | 261,777 |
| 2023-03-31 | Brenner Martin See Remarks | Grant or award | +50,000 | 266,159 | ||
| 2023-03-31 | Duran Felipe Chief Financial Officer | Grant or award | +37,500 | 39,633 | ||
| 2023-03-23 | Brenner Martin See Remarks | Sale | −5,213 | $2.13 | $11K | 216,159 |
| 2023-02-21 | Brenner Martin See Remarks | Sale | −3,976 | $1.77 | $7K | 221,372 |
| 2023-01-20 | Brenner Martin Interim CEO and CSO | Grant or award | +130,000 | 225,348 | ||
| 2022-11-11 | Brenner Martin Chief Scientific Officer | Grant or award | +95,348 | 95,348 | ||
| 2022-11-11 | Lutz Robert Matthew See Remarks | Grant or award | +100,057 | 102,165 | ||
| 2022-09-08 | Isett Thomas Francis 3rd CEO and Executive Chairman | Grant or award · Stock Option (right to buy) | +2,000,000 | 2,000,000 | ||
| 2022-08-29 | Lutz Robert Matthew See Remark | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2022-08-29 | Brenner Martin Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +700,000 | 700,000 | ||
| 2022-03-10 | Lutz Robert Matthew See Remarks | Sale | −24,625 | $0.35 | $9K | 207,375 |
| 2021-12-09 | Clark William D Director | Grant or award · Stock Option (right to buy) | +109,000 | 109,000 | ||
| 2021-12-09 | Schimmelpennink Evert B. Director | Grant or award · Stock Option (right to buy) | +109,000 | 109,000 | ||
| 2021-12-09 | Kropotova Alexandra Director | Grant or award · Stock Option (right to buy) | +109,000 | 109,000 | ||
| 2021-12-09 | Armstrong Linda Washington Director | Grant or award · Stock Option (right to buy) | +109,000 | 109,000 | ||
| 2021-12-09 | Sender Gary Director | Grant or award · Stock Option (right to buy) | +109,000 | 109,000 | ||
| 2021-12-09 | GENERAL HILL (Ret) JAMES T. Director | Grant or award · Stock Option (right to buy) | +109,000 | 109,000 | ||
| 2021-12-09 | MCKEY JOHN D JR Director | Grant or award · Stock Option (right to buy) | +109,000 | 109,000 | ||
| 2021-12-09 | Chang Glenn Director | Grant or award · Stock Option (right to buy) | +109,000 | 109,000 |
Page 4 of 7 · 126 trades